Position in PULM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$208,586
+$67,786 QoQ
Shares Held
122,698
+12.4% QoQ
Ownership
3.36%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 15 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PULM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. PULM ranks #251 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in PULM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $208,586 | 122,698 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $140,800 | 109,148 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $247,351 | 110,920 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $555,935 | 114,390 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $764,658 | 110,820 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $725,407 | 108,920 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $761,657 | 109,120 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $250,850 | 117,220 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $216,584 | 112,220 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $200,935 | 114,820 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $218,217 | 117,321 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $225,867 | 111,265 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $292,152 | 109,012 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $308,410 | 105,620 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $403,985 | 104,120 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $400,625 | 112,220 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $559,612 | 121,920 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $776,024 | 113,620 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,073,363 | 2,450,601 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,154,525 | 2,693,157 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,962,326 | 2,848,391 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,182,900 | 2,393,158 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $3,061,324 | 2,572,542 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,372,823 | 1,993,969 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,881,572 | 1,675,333 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $590,026 | 584,185 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||